Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingyue Wu

Showing results (1-10 of 94) with videos related to

Pageof 10
Sort By:
Advances in Experimental Medicine and Biology|July 17, 2020
Autophagy and Parkinson's DiseaseJiahong Lu, Mingyue Wu, Zhenyu Yue
Chemosphere|August 19, 2021
Association between the urinary nickel and the diastolic blood pressure in general populationYihai Liu, Mingyue Wu, Biao Xu, et al.
Journal of Inflammation Research|June 9, 2021
Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse ModelYihai Liu, Mingyue Wu, Biao Xu, et al.
Cardiology Research and Practice|May 23, 2022
The Beneficial Role of Nrf2 in the Endothelial Dysfunction of AtherosclerosisZixia Huang, Mingyue Wu, Lijin Zeng, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2023
Association between composite dietary antioxidant index and hypertension: insights from NHANESMingyue Wu, Jiayi Si, Yihai Liu, et al.
Cardiology Research and Practice|May 23, 2022
Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic StrategyMingyue Wu, Zixia Huang, Lijin Zeng, et al.
Angiology|January 25, 2022
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery DiseaseYihai Liu, Lei Chang, Mingyue Wu, et al.
Breast Cancer Research and Treatment|January 16, 2009
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysisChunbo Tang, Ning Chen, Mingyue Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2021
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic miceYihai Liu, Mingyue Wu, Jiamin Xu, et al.
Lipids in Health and Disease|January 13, 2021
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityYihai Liu, Jiamin Xu, Mingyue Wu, et al.
Pageof 10

Showing results (1-10 of 94) with videos related to

Sort By:
Pageof 10
Advances in Experimental Medicine and Biology|July 17, 2020
Autophagy and Parkinson's DiseaseJiahong Lu, Mingyue Wu, Zhenyu Yue
Chemosphere|August 19, 2021
Association between the urinary nickel and the diastolic blood pressure in general populationYihai Liu, Mingyue Wu, Biao Xu, et al.
Journal of Inflammation Research|June 9, 2021
Empagliflozin Alleviates Atherosclerosis Progression by Inhibiting Inflammation and Sympathetic Activity in a Normoglycemic Mouse ModelYihai Liu, Mingyue Wu, Biao Xu, et al.
Cardiology Research and Practice|May 23, 2022
The Beneficial Role of Nrf2 in the Endothelial Dysfunction of AtherosclerosisZixia Huang, Mingyue Wu, Lijin Zeng, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 13, 2023
Association between composite dietary antioxidant index and hypertension: insights from NHANESMingyue Wu, Jiayi Si, Yihai Liu, et al.
Cardiology Research and Practice|May 23, 2022
Programmed Cell Death of Endothelial Cells in Myocardial Infarction and Its Potential Therapeutic StrategyMingyue Wu, Zixia Huang, Lijin Zeng, et al.
Angiology|January 25, 2022
Triglyceride Glucose Index Was Associated With the Risk of Peripheral Artery DiseaseYihai Liu, Lei Chang, Mingyue Wu, et al.
Breast Cancer Research and Treatment|January 16, 2009
Fok1 polymorphism of vitamin D receptor gene contributes to breast cancer susceptibility: a meta-analysisChunbo Tang, Ning Chen, Mingyue Wu, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2021
Empagliflozin prevents from early cardiac injury post myocardial infarction in non-diabetic miceYihai Liu, Mingyue Wu, Jiamin Xu, et al.
Lipids in Health and Disease|January 13, 2021
Empagliflozin protects against atherosclerosis progression by modulating lipid profiles and sympathetic activityYihai Liu, Jiamin Xu, Mingyue Wu, et al.
Pageof 10